Arm Holdings plc - American Depositary Shares (ARM)
282.57
-4.11 (-1.43%)
NASDAQ· Last Trade: Aug 8th, 5:54 PM EDT
Detailed Quote
Previous Close
286.68
Open
298.96
Bid
282.31
Ask
283.42
Day's Range
275.00 - 299.29
52 Week Range
100.02 - 452.70
Volume
3,831,201
Market Cap
-
PE Ratio (TTM)
376.76
EPS (TTM)
0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
6,169,204
Chart
About Arm Holdings plc - American Depositary Shares (ARM)
Arm Holdings plc is a leading technology company that specializes in semiconductor and software design, primarily focusing on microprocessor and system-on-chip (SoC) architectures. Its innovative designs are integral to a wide range of applications, from mobile devices to embedded systems and Internet of Things (IoT) products. Arm's technology enables low power consumption and efficient performance, making it a popular choice among manufacturers and developers in the electronics industry. The company collaborates closely with partners to drive the advancement of next-generation computing and connectivity solutions, playing a crucial role in shaping the future of digital devices and applications. Read More
Big celebrations demand a massive upgrade in your social life. If you have a huge birthday coming up or a corporate celebration, showing up alone is a terr
A five-star hotel by itself doesn't make a trip memorable anymore, not for people who've already stayed there. What tends to stick is something smaller and
Twenty-four immigration providers operating in Tbilisi were assessed for the 2026 Best Immigration Lawyers in Tbilisi ranking published by TbilisiExperts.ge, measured on published fee transparency, verifiable company identity, whether the provider represents clients in administrative appeals, and whether an enquiry written in English reaches a person rather than a form.
BIRMINGHAM, Ala. - Cory Watson Attorneys is proud to welcome Chrissy Tubbs as the newest associate attorney to the firm's growing legal team. Tubbs joins the firm with a passion for advocating on behalf of individuals and families whose lives have been impacted by serious injuries and catastrophic events, bringing both compassion and determination to every client she serves.
The HEAL and RISE initiative expands into a tri-country movement supporting youth and women's mental health through expanded awareness, advocacy, and community programs across three nations, by Beyond The Call 24/7.
Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program.
Chairman, Chief Executive Officer and Co-Founder Shankar Musunuri sa
Intellia Therapeutics (NASDAQ:NTLA) said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the resumption of enrollment in Phase III studies of nex-z for transthyretin amyloidosis.
Chief Executive O
Church & Dwight delivered a positive second quarter, with management highlighting broad-based organic sales growth across its divisions and strong consumer d...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Best PRP P-Shot Clinic in Dubai | Glamorous Clinic in DubaiMen’s wellness is an important part of confidence, comfort, and overall quality of life. With ad
ALPHARETTA, GA - August 05, 2026 - Complete Family Healthcare provides whiplash treatment as part of its chiropractic services for patients recovering from motor vehicle accidents and other incidents that...
The company's 2018 decision to stop reporting unit sales in 2019 means investors aren't seeing the full bullish story. Fortunately, IDC is still keeping score.
Arm Holdings (ARM) stock surged over 11% on Tuesday after analysts highlighted 100%+ year-over-year data center royalty growth and strong AI chip demand.
Modern enterprise security teams face endless streams of network alerts every day. Organizations deploy a unified security platform to consolidate critical
For years, biotech investors have often evaluated oncology companies through familiar milestones, including tumor response rates, progression-free survival, and regulatory designations. While each remains important, another endpoint has begun attracting greater attention from researchers and clinicians alike: overall survival .
